| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.987 | 1 | 0 | 1994 | 2020 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 | 1.000 | 0.115 | 1.7E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 0.705 | 0.500 | 0.89 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 1988 | 2013 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.490 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 4 | 0 | 1989 | 2020 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.400 | None | 0.966 | 1 | 0 | 2003 | 2019 | ||||||||
|
TNF superfamily member 14 | 0.529 | 0.769 | 5.2E-02 |
|
disease | 0.390 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
TNF receptor superfamily member 14 | 0.568 | 0.731 | 0.81 |
|
disease | 0.380 | None | 0.889 | 1 | 0 | 2003 | 2017 | ||||||||
|
TNF receptor superfamily member 11b | 0.422 | 0.808 | 0.16 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 2001 | 2019 | ||||||||
|
TNF receptor associated factor 6 | 0.472 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
TNF receptor associated factor 1 | 0.554 | 0.731 | 3.6E-03 |
|
disease | 0.500 | None | 0.850 | 2 | 0 | 2007 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
TNF alpha induced protein 2 | 0.711 | 0.423 | 8.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
TLE family member 3, transcriptional corepressor | 0.674 | 0.462 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
thymopoietin | 0.631 | 0.577 | 1.5E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
thioredoxin interacting protein | 0.490 | 0.731 | 0.16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
thioredoxin domain containing 5 | 0.615 | 0.577 | 4.9E-13 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
T cell activation RhoGTPase activating protein | 0.700 | 0.462 | 0.85 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.340 | None | 0.714 | 3 | 0 | 2000 | 2019 | ||||||||
|
steroid sulfatase | 0.431 | 0.846 | 0.81 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | 0.729 | 0.346 | 0.17 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
sprouty related EVH1 domain containing 2 | 0.711 | 0.577 | 2.9E-07 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2010 | 2019 | ||||||||
|
spermine synthase | 0.491 | 0.846 | 0.97 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
solute carrier family 25 member 12 | 0.711 | 0.462 | 0.22 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 |